Business description: Macro Group Pharmaceuticals (Macro Capital) S.A.E

Macro Group Pharmaceutical S.A.E. (Macro Capital) is specialized in developing, manufacturing and marketing pharmaceuticals. The company's products include anti-scar, skincare, antiseptic, hair care, oral care and muscle relaxant medicines. In addition, the group offers plant-based medicines.

At the end of 2021, Macro Group Pharmaceutical S.A.E. (Macro Capital) had one production site in Egypt.

Sales by Activity: Macro Group Pharmaceuticals (Macro Capital) S.A.E

Fiscal Period: December 2021 (EGP) 2022 (EGP) 2023 (EGP) 2024 (EGP) 2025 (EGP)

Manufacture and Sale of Pharmaceuticals

594M 730M 526M 520M 895M

Geographical breakdown of sales: Macro Group Pharmaceuticals (Macro Capital) S.A.E

Fiscal Period: December 2021 (EGP) 2022 (EGP) 2023 (EGP) 2024 (EGP) 2025 (EGP)

Egypt

- 699M 511M 485M 864M

Export

- 30.46M 15.02M 34.67M 30.8M

Executive Committee: Macro Group Pharmaceuticals (Macro Capital) S.A.E

Manager TitleAgeSince
Chief Executive Officer - -
Investor Relations Contact - -
Sales & Marketing - 2021-12-31
Human Resources Officer - 2022-10-31

Composition of the Board of Directors: Macro Group Pharmaceuticals (Macro Capital) S.A.E

Director TitleAgeSince
Chairman - 2001-12-31
Director/Board Member - 2020-12-31
Director/Board Member - 2020-12-31
Director/Board Member 54 2020-12-31
Director/Board Member 38 2020-12-31
Director/Board Member - 2020-12-31

Company details: Macro Group Pharmaceuticals (Macro Capital) S.A.E

Macro Group Pharmaceutical SAE

83, Al Moltaka Al Arabi

, Sheraton

+

http://www.macro-egy.com
address Macro Group Pharmaceuticals (Macro Capital) S.A.E(MCRO)

Other Pharmaceuticals

Change 5-day change 1-year change 3-year change Capi.($)
+5.19%+10.08%-56.97%-42.97% 85.71M
+1.44%+1.63%+48.17%+139.63% 1,258B
-0.47%+5.49%+49.03%+90.68% 679B
+0.20%+2.76%+34.37%+112.06% 518B
+0.17%+2.76%+44.07%+69.71% 390B
-0.48%+2.34%+70.66%+46.02% 367B
+0.76%+2.27%+31.59%+60.36% 307B
-1.29%+0.90%+5.77%+37.60% 293B
0.00%+0.86%+43.74%+74.04% 252B
+0.92%+2.03%+44.62%+125.07% 210B
Average +0.49%+1.70%+31.51%+71.22% 427B
Weighted average by Cap. -0.09%+1.18%+43.66%+96.83%
  1. Stock Market
  2. Stocks
  3. MCRO Stock
  4. Company Macro Group Pharmaceuticals (Macro Capital) S.A.E